| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 0 | 434.333 | 1.524.855 | 1.157.159 | 2.066.535 | 1.898.582 |
| Total Income - EUR | - | - | - | 0 | 0 | 434.639 | 1.525.414 | 1.159.115 | 2.068.451 | 1.900.589 |
| Total Expenses - EUR | - | - | - | 0 | 1.042 | 247.398 | 1.264.111 | 1.147.532 | 1.744.705 | 2.422.342 |
| Gross Profit/Loss - EUR | - | - | - | 0 | -1.042 | 187.241 | 261.303 | 11.583 | 323.746 | -521.753 |
| Net Profit/Loss - EUR | - | - | - | 0 | -1.042 | 183.149 | 242.299 | 5.369 | 273.808 | -521.753 |
| Employees | - | - | - | 0 | 0 | 1 | 10 | 0 | 11 | 30 |
Check the financial reports for the company - Genekor Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 6.555 | 9.465 | 42.306 | 977.053 |
| Current Assets | - | - | - | 215 | 660 | 333.877 | 689.655 | 323.040 | 572.254 | 158.070 |
| Inventories | - | - | - | 0 | 19 | 176 | 146 | 3.561 | 17.106 | 1.732 |
| Receivables | - | - | - | 0 | 0 | 186.551 | 335.911 | 61.785 | 137.533 | 91.466 |
| Cash | - | - | - | 215 | 641 | 147.150 | 353.598 | 257.694 | 417.615 | 64.873 |
| Shareholders Funds | - | - | - | 215 | -857 | 182.308 | 414.845 | 220.750 | 493.889 | -30.624 |
| Social Capital | - | - | - | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | - | - | - | 0 | 1.517 | 151.568 | 281.540 | 119.907 | 129.305 | 1.172.736 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Genekor Medical S.r.l.